Veloxity Labs’ President and CEO, Shane Needham, will participate in the panel discussion “Industry, Policy & Emerging Markets.”

The session will bring together leaders from pharmaceutical manufacturing, medical device manufacturing, healthcare, the blood supply chain and public policy to explore the evolving landscape of bioscience and healthcare innovation.

Panelists will discuss real-world challenges and opportunities shaping the industry today, including regulatory environments, operational scaling, workforce development and the intersection of policy and emerging markets.

The conversation will highlight how industry leaders are navigating these dynamics while advancing new technologies and expanding access to life-changing therapies.

Veloxity looks forward to contributing perspective from the bioanalytical sector and connecting with fellow innovators across the bioscience ecosystem.